These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 1331290)

  • 41. Identification and deletion of sequences required for feline leukemia virus RNA packaging and construction of a high-titer feline leukemia virus packaging cell line.
    Burns CC; Moser M; Banks J; Alderete JP; Overbaugh J
    Virology; 1996 Aug; 222(1):14-20. PubMed ID: 8806483
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Host range and receptor binding properties of vectors bearing feline leukemia virus subgroup B envelopes can be modulated by envelope sequences outside of the receptor binding domain.
    Faix PH; Feldman SA; Overbaugh J; Eiden MV
    J Virol; 2002 Dec; 76(23):12369-75. PubMed ID: 12414980
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A replication-competent feline leukemia virus, subgroup A (FeLV-A), tagged with green fluorescent protein reporter exhibits in vitro biological properties similar to those of the parental FeLV-A.
    Chang Z; Pan J; Logg C; Kasahara N; Roy-Burman P
    J Virol; 2001 Sep; 75(18):8837-41. PubMed ID: 11507228
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pathogenicity of feline leukemia virus is commonly associated with variant viruses.
    Jarrett O
    Leukemia; 1992; 6 Suppl 3():153S-154S. PubMed ID: 1318467
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantification of endogenous and exogenous feline leukemia virus sequences by real-time PCR assays.
    Tandon R; Cattori V; Willi B; Lutz H; Hofmann-Lehmann R
    Vet Immunol Immunopathol; 2008 May; 123(1-2):129-33. PubMed ID: 18295344
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Distinctive receptor binding properties of the surface glycoprotein of a natural feline leukemia virus isolate with unusual disease spectrum.
    Bolin LL; Chandhasin C; Lobelle-Rich PA; Albritton LM; Levy LS
    Retrovirology; 2011 May; 8():35. PubMed ID: 21569491
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Feline Pit2 functions as a receptor for subgroup B feline leukemia viruses.
    Anderson MM; Lauring AS; Robertson S; Dirks C; Overbaugh J
    J Virol; 2001 Nov; 75(22):10563-72. PubMed ID: 11602698
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Three distinct envelope domains, variably present in subgroup B feline leukemia virus recombinants, mediate Pit1 and Pit2 receptor recognition.
    Boomer S; Eiden M; Burns CC; Overbaugh J
    J Virol; 1997 Nov; 71(11):8116-23. PubMed ID: 9343161
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structure and pathogenicity of individual variants within an immunodeficiency disease-inducing isolate of FeLV.
    Overbaugh J; Hoover EA; Mullins JI; Burns DP; Rudensey L; Quackenbush SL; Stallard V; Donahue PR
    Virology; 1992 Jun; 188(2):558-69. PubMed ID: 1316674
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transduction of Notch2 in feline leukemia virus-induced thymic lymphoma.
    Rohn JL; Lauring AS; Linenberger ML; Overbaugh J
    J Virol; 1996 Nov; 70(11):8071-80. PubMed ID: 8892932
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vivo evolution and selection of recombinant feline leukemia virus species.
    Bechtel MK; Mathes LE; Hayes KA; Phipps AJ; Roy-Burman P
    Virus Res; 1998 Mar; 54(1):71-86. PubMed ID: 9660073
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Refrex-1, a soluble restriction factor against feline endogenous and exogenous retroviruses.
    Ito J; Watanabe S; Hiratsuka T; Kuse K; Odahara Y; Ochi H; Kawamura M; Nishigaki K
    J Virol; 2013 Nov; 87(22):12029-40. PubMed ID: 23966402
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interference with superinfection and with cell killing and determination of host range and growth kinetics mediated by feline leukemia virus surface glycoproteins.
    Kristal BS; Reinhart TA; Hoover EA; Mullins JI
    J Virol; 1993 Jul; 67(7):4142-53. PubMed ID: 8389921
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Disease-specific and tissue-specific production of unintegrated feline leukaemia virus variant DNA in feline AIDS.
    Mullins JI; Chen CS; Hoover EA
    Nature; 1986 Jan 23-29; 319(6051):333-6. PubMed ID: 3001539
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytopathic feline leukemia viruses cause apoptosis in hemolymphatic cells.
    Rojko JL; Hartke JR; Cheney CM; Phipps AJ; Neil JC
    Prog Mol Subcell Biol; 1996; 16():13-43. PubMed ID: 8822790
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular pathogenesis of feline leukemia virus-induced malignancies: insertional mutagenesis.
    Fujino Y; Ohno K; Tsujimoto H
    Vet Immunol Immunopathol; 2008 May; 123(1-2):138-43. PubMed ID: 18313764
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ancestral Mutations Acquired in Refrex-1, a Restriction Factor against Feline Retroviruses, during its Cooption and Domestication.
    Ito J; Baba T; Kawasaki J; Nishigaki K
    J Virol; 2016 Feb; 90(3):1470-85. PubMed ID: 26581999
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibodies neutralizing feline leukaemia virus (FeLV) in cats immunized with the transmembrane envelope protein p15E.
    Langhammer S; Hübner J; Kurth R; Denner J
    Immunology; 2006 Feb; 117(2):229-37. PubMed ID: 16423059
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The frequency of occurrence and nature of recombinant feline leukemia viruses in the induction of multicentric lymphoma by infection of the domestic cat with FeLV-945.
    Ahmad S; Levy LS
    Virology; 2010 Aug; 403(2):103-10. PubMed ID: 20451235
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Haemadsorption and haemagglutination by feline leukaemia viruses.
    Mochizuki M; Jarrett O
    J Gen Virol; 1985 Feb; 66 ( Pt 2)():385-9. PubMed ID: 2981974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.